Oruka Therapeutics Is Priced For Perfection - It’s Time To Cash Out (NASDAQ:ORKA)
· seekingalpha.com
Oruka Therapeutics is rated a Sell, and its current valuation far exceeds risk-adjusted fundamentals. Read more on ORKA stock here.
Investors in ORKA have had a phenomenal year, with the price up more than 600% over the last 12 months. I believe it is now time to take the cash and look elsew...